Brief: Oncoarendi Therapeutics To Withdraw From In Consortium Deal With ABM

Molecure SA

10/02/2022 17:04

Feb 10 (Reuters) - Oncoarendi Therapeutics SA  OAT.WA :
    * TO WITHDRAW FROM IN CONSORTIUM DEAL WITH ABM ON PROJECT
REGARDING DISCOVERY AND DEVELOPMENT OF NOVEL ANTIVIRAL DRUGS
DESTABILIZING RNA OF CORONAVIRUSES
    * THIS DECISION RESULTS FROM DIFFERENCES IN UNDERSTANDING OF
DRAFT
DEAL IN TERMS OF SECURING ITS EXECUTION BETWEEN COMPANY AND ABM

Source text for Eikon:  ID:nEM406cmxa 
Further company coverage:  OAT.WA 

 (Reporting by Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com;))